Redpoint Bio terminates collaboration and licensing agreement with Givaudan
Ray Salemme, CEO of Redpoint Bio, said: “While we are disappointed with the conclusion of our partnership with Givaudan, we believe that Redpoint’s technology platform continues to provide
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.